Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Cytarabine + glasdegib is approved for Acute myeloid leukemia (AML) by the FDA and in Europe. However, low-dose cytarabine (LDAC), not general or intensive-dose cytarabine.
(1) fda-approves-glasdegib-aml-adults-age-75-or-older-or-who-have-comorbidities
(2) [Daurismo | European Medicines Agency (…